Sign in
4/A

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-064501

Options or other derivatives

  • Chief Operations Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Newell Joe Chief Operations Officer 2020-11-13 Option exercise · Employee Stock Option (Right to Buy) −667 52,333 D
Newell Joe Chief Operations Officer 2020-11-13 Option exercise · Employee Stock Option (Right to Buy) −2,833 14,167 D
Loading xslF345X03/doc4a.xml…